Vanda Pharmaceuticals (VNDA) - News Mentions

Sign up to add (VNDA) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 100%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Vanda Pharmaceuticals Inc.(NasdaqGM: VNDA) added to Russell 2000 Value-Defensive Index
June 30
Vanda Pharmaceuticals Inc.(NasdaqGM: VNDA) added to Russell 2000 Defensive Index
June 29
Vanda Pharmaceuticals (NASDAQ:VNDA) Upgraded by Wall Street Zen to Hold Rating
June 15
Brokers Offer Predictions for VNDA FY2026 Earnings
June 11
Vanda Pharmaceuticals Inc. Announces First Patient Dosed in A Trial Evaluating VCA-894A in Charcot-Marie-Tooth Disease Type 2S
June 9
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S
June 9
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Sold by Jane Street Group LLC
June 8
Two Sigma Investments LP Boosts Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
June 7
Public Employees Retirement System of Ohio Has $426,000 Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
June 5
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Acquired by Two Sigma Advisers LP
June 3
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
May 26
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Sold by Lazard Asset Management LLC
May 25
Northern Trust Corp Boosts Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
May 25
Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Overweight Rating from Cantor Fitzgerald
May 16
HC Wainwright Issues Pessimistic Estimate for VNDA Earnings
May 16
Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
May 16

Month over Month

Est. daily news mentions.

Jun 2025 0
May 2025 0
Apr 2025 0
Mar 2025 0
Feb 2025 0

How often is Vanda Pharmaceuticals mentioned in the news?

Vanda Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Vanda Pharmaceuticals performing compared to its industry peers?

Vanda Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Vanda Pharmaceuticals in the last month?

Vanda Pharmaceuticals' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Vanda Pharmaceuticals?

By monitoring mentions in the news for Vanda Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Vanda Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Vanda Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.